Christophe Saint‐Etienne

Author

Centre Hospitalier Universitaire de Tours

Also Known As

C Saint-Etienne, C. Saint-Etienne, C. Saint-Étienne, Christophe SAINT-ETIENNE, Christophe Saint-Etienne, Christophe Saint‐Etienne, Laurent-Emmanuel Quilliet, Marc Bedossa, Mathieu Kerneis, Saint-Etienne, Christophe

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Tours Sorbonne Université Inserm Hôpital Lariboisière Assistance Publique – Hôpitaux de Paris

About

Christophe Saint‐Etienne is an author at Centre Hospitalier Universitaire de Tours specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	813
2	Vascular Surgery	2	2	329
3	Public Health	1	1	31
4	Emergency Medicine	1	1	362
5	Pharmacology	1	1	122

Christophe Saint‐Etienne

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting Jean‐Philippe Collet, Thomas Cuisset, Grégoire Rangé, New England Journal of Medicine	2012	871
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial Guillaume Cayla, Thomas Cuisset, Johanne Silvain, The Lancet ThrombosisPercutaneous Coronary InterventionSuperiority TrialPlatelet Function MonitoringCardiovascular Disease	2016	362
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial Jean‐Philippe Collet, Johanne Silvain, Olivier Barthélémy, The Lancet Drug-eluting Stent ImplantationThrombosisDual-antiplatelet TreatmentEndovascular TechniqueCardiovascular Disease	2014	298
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Johanne Silvain, Benoît Lattuca, Farzin Beygui, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineCardiovascular Pharmacology	2020	122
High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization Gilles Montalescot, Grégoire Rangé, Johanne Silvain, Circulation	2014	56
Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry Didier Tchétché, Francesca Ziviello, Chiara De Biase, EuroIntervention	2023	41
Incidence, predictors, impact, and treatment of vascular complications after transcatheter aortic valve implantation in a modern prospective cohort under real conditions Q. Langouet, Robert Martinez, Christophe Saint‐Etienne, Journal of Vascular Surgery Endovascular TechniqueCardiovascular DiseaseReal ConditionsVascular SurgeryVascular Complications	2020	31
Are Central Venous Lactate and Arterial Lactate Interchangeable? A Human Retrospective Study François Réminiac, Christophe Saint‐Etienne, Isabelle Runge, Anesthesia & Analgesia	2012	27
Perforation of the atretic pulmonary valve using chronic total occlusion (CTO) wire and coronary microcatheter Bruno Lefort, Christophe Saint‐Etienne, Nathalie Soulé, Congenital Heart Disease	2019	16
Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC Trial Benoît Lattuca, Guillaume Cayla, Johanne Silvain, American Journal of Cardiovascular Drugs	2021	16

Page 1